APA (7th ed.) Citation

Y, C., Y, C., X, Z., F, M., Y, T., W, W., . . . S, Y. (2026). The antidepressants and sexual dysfunction: A pharmacovigilance-pharmacodynamic study of the FDA adverse event reporting system. Expert opinion on drug safety, 25(5), 897. https://doi.org/10.1080/14740338.2024.2443956

Chicago Style (17th ed.) Citation

Y, Cheng, Chen Y, Zhao X, Mou F, Tan Y, Wang W, Qian R, Xu Q, and Yu S. "The Antidepressants and Sexual Dysfunction: A Pharmacovigilance-pharmacodynamic Study of the FDA Adverse Event Reporting System." Expert Opinion on Drug Safety 25, no. 5 (2026): 897. https://doi.org/10.1080/14740338.2024.2443956.

MLA (9th ed.) Citation

Y, Cheng, et al. "The Antidepressants and Sexual Dysfunction: A Pharmacovigilance-pharmacodynamic Study of the FDA Adverse Event Reporting System." Expert Opinion on Drug Safety, vol. 25, no. 5, 2026, p. 897, https://doi.org/10.1080/14740338.2024.2443956.